PortalPublikationenTranslating the molecular diversity of hepatocellular carcin...

Translating the molecular diversity of hepatocellular carcinoma into clinical practice

Standard

Translating the molecular diversity of hepatocellular carcinoma into clinical practice. / Schulze, Kornelius; Zucman-Rossi, Jessica.

in: MOL CELL ONCOL, Jahrgang 3, Nr. 4, 07.2016, S. e1057316.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Zeitungsartikel › Transfer

Harvard

Schulze, K & Zucman-Rossi, J 2016, 'Translating the molecular diversity of hepatocellular carcinoma into clinical practice', MOL CELL ONCOL, Jg. 3, Nr. 4, S. e1057316. https://doi.org/10.1080/23723556.2015.1057316

APA

Schulze, K., & Zucman-Rossi, J. (2016). Translating the molecular diversity of hepatocellular carcinoma into clinical practice. MOL CELL ONCOL, 3(4), e1057316. https://doi.org/10.1080/23723556.2015.1057316

Vancouver

Schulze K, Zucman-Rossi J. Translating the molecular diversity of hepatocellular carcinoma into clinical practice. MOL CELL ONCOL. 2016 Jul;3(4):e1057316. https://doi.org/10.1080/23723556.2015.1057316

Bibtex

@article{ab89947668e1425fab59cac3bb8c0e93,
title = "Translating the molecular diversity of hepatocellular carcinoma into clinical practice",
abstract = "Deciphering genomic diversity could improve clinical care for patients with hepatocellular carcinoma. Recently, our study group identified 161 putative driver genes and 2 new mutational signatures, and demonstrated that 28% of patients harbor targetable alterations. This could be the first promising step in the development of genome-based clinical trials.",
keywords = "Journal Article",
author = "Kornelius Schulze and Jessica Zucman-Rossi",
year = "2016",
month = jul,
doi = "10.1080/23723556.2015.1057316",
language = "English",
volume = "3",
pages = "e1057316",
journal = "MOL CELL ONCOL",
issn = "2372-3556",
publisher = "Taylor and Francis Ltd.",
number = "4",

}

RIS

TY - JOUR

T1 - Translating the molecular diversity of hepatocellular carcinoma into clinical practice

AU - Schulze, Kornelius

AU - Zucman-Rossi, Jessica

PY - 2016/7

Y1 - 2016/7

N2 - Deciphering genomic diversity could improve clinical care for patients with hepatocellular carcinoma. Recently, our study group identified 161 putative driver genes and 2 new mutational signatures, and demonstrated that 28% of patients harbor targetable alterations. This could be the first promising step in the development of genome-based clinical trials.

AB - Deciphering genomic diversity could improve clinical care for patients with hepatocellular carcinoma. Recently, our study group identified 161 putative driver genes and 2 new mutational signatures, and demonstrated that 28% of patients harbor targetable alterations. This could be the first promising step in the development of genome-based clinical trials.

KW - Journal Article

U2 - 10.1080/23723556.2015.1057316

DO - 10.1080/23723556.2015.1057316

M3 - Newspaper articles

C2 - 27652310

VL - 3

SP - e1057316

JO - MOL CELL ONCOL

JF - MOL CELL ONCOL

SN - 2372-3556

IS - 4

ER -